Low‐ and high‐dose radioiodine ablation for low‐/intermediate‐risk differentiated thyroid cancer in China: Large randomized clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low‐ and high‐dose radioiodine ablation for low‐/intermediate‐risk differentiated thyroid cancer in China: Large randomized clinical trial

Published:2021-01-19 Issue:4 Volume:43 Page:1311-1320
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Dong Ping¹,Wang Li²,Qu Yuan³,Huang Rui¹,Li Lin¹^ORCID

Affiliation:

1. Department of Nuclear Medicine, West China Hospital Sichuan University Chengdu China

2. Department of Pancreatic Surgery, West China Hospital Sichuan University Chengdu China

3. Department of Medical Imaging, East Hospital Tongji University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.26594

Reference29 articles.

1. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

2. Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients

3. Low-Risk Differentiated Thyroid Cancer and Radioiodine Remnant Ablation: A Systematic Review of the Literature

4. The Effectiveness of Radioactive Iodine for Treatment of Low-Risk Thyroid Cancer: A Systematic Analysis of the Peer-Reviewed Literature from 1966 to April 2008

5. An Updated Systematic Review and Commentary Examining the Effectiveness of Radioactive Iodine Remnant Ablation in Well-Differentiated Thyroid Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ablation Rates and Long-Term Outcome Following Low-Dose Radioiodine for Differentiated Thyroid Cancer in the West of Scotland: A Retrospective Analysis;Endocrine Practice;2024-04

2. Assessment of three different radioiodine doses for ablation therapy of thyroid remnants: Efficiency, complications and patient comfort;Medicine;2023-09-29

3. Factors Affecting Ablation Success After I-131 Radioactive Iodine Therapy in Low and Intermediate Risk Papillary Thyroid Cancer;Hormone and Metabolic Research;2023-06-02

4. Comparison of Radioactive Iodine Activities in Terms of Short- and Long-term Results in Ablation Therapy in Patients with Low-risk Differentiated Thyroid Cancer;Molecular Imaging and Radionuclide Therapy;2023-06-01

5. Radioiodine (131I) treatment decision-making for low- and intermediate-risk differentiated thyroid cancer;Archives of Endocrinology and Metabolism;2023-01-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3